"Advanced cancer care by experienced oncologists with a focus on patient comfort, convenience and cost control is how we fight cancer. FWMOH is the area's leader in clinical trials, giving you access to breakthrough treatments. Our doctors see patients at 13 northeast Indiana locations and Hicksville, OH, bringing care to your hometown. Walk-in and same-day appointments are available in Fort Wayne. Call (260) 484-8830 and we'll schedule an appointment within just days, not weeks. Cancer won't wait. Neither should you. No referral is necessary."

During the past decade, Fort Wayne Medical Oncology and Hematology Inc-Parkview conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 142 clinical trials were completed, i.e. on average, 197.2% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 47 clinical trials were completed. i.e. 134.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fort Wayne Medical Oncology and Hematology Inc-Parkview" #1 sponsor was "National Cancer Institute (NCI)" with 80 trials, followed by "Alliance for Clinical Trials in Oncology" with 51 trials sponsored, "University of Chicago" with 20 trials sponsored, "Hoosier Cancer Research Network" with 15 trials sponsored and "Bristol-Myers Squibb" with 15 trials sponsored. Other sponsors include 103 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fort Wayne Medical Oncology and Hematology Inc-Parkview" #1 collaborator was "National Cancer Institute (NCI)" with 100 trials as a collaborator, "Walther Cancer Institute" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 109 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Fort Wayne Medical Oncology and Hematology Inc-Parkview" are "Breast Cancer" (22 trials), "Lung Cancer" (16 trials), "Colorectal Cancer" (14 trials), "Leukemia" (14 trials) and "Lymphoma" (14 trials). Many other conditions were trialed in "Fort Wayne Medical Oncology and Hematology Inc-Parkview" in a lesser frequency.

Most popular intervention types in "Fort Wayne Medical Oncology and Hematology Inc-Parkview" are "Drug" (258 trials), "Other" (91 trials), "Biological" (73 trials), "Procedure" (30 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (60 trials), "Bevacizumab" (23 trials), "Placebo" (19 trials), "Paclitaxel" (17 trials) and "Quality-of-Life Assessment" (17 trials). Other intervention names were less common.

The vast majority of trials in "Fort Wayne Medical Oncology and Hematology Inc-Parkview" are 234 trials for "All" genders, 33 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are NaN active trials in "Fort Wayne Medical Oncology and Hematology Inc-Parkview". undefined are not yet recruiting, 20 are recruiting, 60 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 162 completed trials in Fort Wayne Medical Oncology and Hematology Inc-Parkview, undefined suspended trials, and 41 terminated clinical trials to date.

Out of the total trials that were conducted in Fort Wayne Medical Oncology and Hematology Inc-Parkview, 29 "Phase 1" clinical trials were conducted, 155 "Phase 2" clinical trials and 106 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".